Page last updated: 2024-10-20

urea and Pulmonary Alveolar Proteinosis

urea has been researched along with Pulmonary Alveolar Proteinosis in 1 studies

pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.

Pulmonary Alveolar Proteinosis: A PULMONARY ALVEOLI-filling disease, characterized by dense phospholipoproteinaceous deposits in the alveoli, cough, and DYSPNEA. This disease is often related to, congenital or acquired, impaired processing of PULMONARY SURFACTANTS by alveolar macrophages, a process dependent on GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Strong, P1
Kishore, U1
Morgan, C1
Lopez Bernal, A1
Singh, M1
Reid, KB1

Other Studies

1 other study available for urea and Pulmonary Alveolar Proteinosis

ArticleYear
A novel method of purifying lung surfactant proteins A and D from the lung lavage of alveolar proteinosis patients and from pooled amniotic fluid.
    Journal of immunological methods, 1998, Nov-01, Volume: 220, Issue:1-2

    Topics: Amniotic Fluid; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; Centrifugation; Chlorides; Chro

1998